| P50 | author | Yen-Sung Huang | Q55266809 |
| P2093 | author name string | Hsiu-Ming Shih | |
| | Yi-Chen Chen | |
| | Cheng-Wen Wu | |
| | Yu-Wei Chang | |
| | Hong-Yi Kuo | |
| | Chin-Hsiu Tseng | |
| P2860 | cites work | Global cancer statistics | Q22241238 |
| | The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein | Q24297944 |
| | PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR | Q24300018 |
| | AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation | Q24306227 |
| | Tyrosine phosphorylation controls PCNA function through protein stability | Q24317732 |
| | A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression | Q24322269 |
| | EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment | Q24338426 |
| | Opposing effects of PML and PML/RAR alpha on STAT3 activity | Q28198442 |
| | Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways | Q28274882 |
| | Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 |
| | Immunologic therapy of multiple sclerosis | Q33540277 |
| | Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer | Q33578803 |
| | Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1 | Q33744538 |
| | Nuclear trafficking of the epidermal growth factor receptor family membrane proteins | Q33998459 |
| | COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport | Q34109724 |
| | RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus | Q34136636 |
| | Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma | Q34283213 |
| | Loss of the tumor suppressor PML in human cancers of multiple histologic origins | Q34299352 |
| | PML-mediated signaling and its role in cancer stem cells | Q34337626 |
| | Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model | Q34343680 |
| | The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus | Q34352437 |
| | Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells | Q35063410 |
| | Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor | Q36054625 |
| | Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells | Q36137373 |
| | Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776. | Q36225686 |
| | Matrix metalloproteinases and tumor metastasis | Q36471104 |
| | Integrative analyses identify osteopontin, LAMB3 and ITGB1 as critical pro-metastatic genes for lung cancer. | Q36618490 |
| | Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer | Q36920432 |
| | Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer | Q37282661 |
| | Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking | Q37417599 |
| | Co-regulation of B-Myb expression by E2F1 and EGF receptor | Q38318606 |
| | The PML isoform IV is a negative regulator of nuclear EGFR's transcriptional activity in lung cancer | Q39170227 |
| | Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity | Q39360651 |
| | Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654 | Q39670051 |
| | Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta | Q39778480 |
| | Nuclear EGFR contributes to acquired resistance to cetuximab | Q39812008 |
| | Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway | Q40410769 |
| | Nuclear localization of EGF receptor and its potential new role as a transcription factor | Q40782527 |
| | Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells | Q40847270 |
| | Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line | Q41089777 |
| | Nuclear EGFR is required for cisplatin resistance and DNA repair | Q41953402 |
| | PML: An emerging tumor suppressor and a target with therapeutic potential. | Q41971647 |
| | miR‑133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP‑14. | Q45993947 |
| | Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells | Q46198272 |
| | Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis | Q47677996 |
| | Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. | Q48068389 |
| | Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma | Q48323889 |
| | Epidermal Growth Factor Receptors Control Competence to Interpret Leukemia Inhibitory Factor as an Astrocyte Inducer in Developing Cortex | Q48324514 |
| | Characterization of a novel tripartite nuclear localization sequence in the EGFR family. | Q50698452 |
| | EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. | Q54638194 |
| | Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis. | Q54699349 |
| | Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis | Q78590833 |
| | Relationship between matrix metalloproteinase 2 and lung cancer progression | Q80481862 |
| | Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer | Q80954371 |
| | Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival | Q84066257 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 19 | |
| P921 | main subject | cancer metastasis | Q120912394 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 3132-3142 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Cell Cycle | Q1254166 |
| P1476 | title | PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2 | |
| P478 | volume | 13 | |